Coronavirus envelope protein: current knowledge

Abstract

BACKGROUND: Coronaviruses (CoVs) primarily cause enzootic infections in birds and mammals but, in the last few decades, have shown to be capable of infecting humans as well. The outbreak of severe acute respiratory syndrome (SARS) in 2003 and, more recently, Middle-East respiratory syndrome (MERS) has demonstrated the lethality of CoVs when they cross the species barrier and infect humans. A renewed interest in coronaviral research has led to the discovery of several novel human CoVs and since then much progress has been made in understanding the CoV life cycle. The CoV envelope (E) protein is a small, integral membrane protein involved in several aspects of the virus' life cycle, such as assembly, budding, envelope formation, and pathogenesis. Recent studies have expanded on its structural motifs and topology, its functions as an ion-channelling viroporin, and its interactions with both other CoV proteins and host cell proteins. MAIN BODY: This review aims to establish the current knowledge on CoV E by highlighting the recent progress that has been made and comparing it to previous knowledge. It also compares E to other viral proteins of a similar nature to speculate the relevance of these new findings. Good progress has been made but much still remains unknown and this review has identified some gaps in the current knowledge and made suggestions for consideration in future research. CONCLUSIONS: The most progress has been made on SARS-CoV E, highlighting specific structural requirements for its functions in the CoV life cycle as well as mechanisms behind its pathogenesis. Data shows that E is involved in critical aspects of the viral life cycle and that CoVs lacking E make promising vaccine candidates. The high mortality rate of certain CoVs, along with their ease of transmission, underpins the need for more research into CoV molecular biology which can aid in the production of effective anti-coronaviral agents for both human CoVs and enzootic CoVs.

Cited by papers we hold 45

• The role of severe acute respiratory syndrome coronavirus 2 viroporins in inflammation · 2022
  Not checked
• Structural biology of SARS-CoV-2: open the door for novel therapies · 2022
  No notice
• SARS-CoV-2 nucleocapsid protein adheres to replication organelles before viral assembly at the Golgi/ERGIC and lysosome-mediated egress · 2022
  No notice
• Perceived impact of the COVID-19 pandemic on orthodontic practice in the Middle East · 2021
  Not checked
• COVID-19: Characteristics and Therapeutics · 2021
  No notice
• Role of IgG against N-protein of SARS-CoV2 in COVID19 clinical outcomes · 2021
  Not checked
• Structural basis for SARS-CoV-2 envelope protein recognition of human cell junction protein PALS1 · 2021
  Not checked
• Persistence of Pathogens on Inanimate Surfaces: A Narrative Review · 2021
  No notice
• De novo design and bioactivity prediction of SARS-CoV-2 main protease inhibitors using recurrent neural network-based transfer learning · 2021
  Not checked
• Molecular testing and analysis of disease spreading during the emergence of COVID-19 in Macaé, the Brazilian National Capital of Oil · 2021
  Not checked
• Role of Structural and Non-Structural Proteins and Therapeutic Targets of SARS-CoV-2 for COVID-19 · 2021
  No notice
• Wuhan to World: The COVID-19 Pandemic · 2021
  No notice
• SARS-CoV-2 envelope protein causes acute respiratory distress syndrome (ARDS)-like pathological damages and constitutes an antiviral target · 2021
  No notice
• Interactions of SARS-CoV-2 with the Blood–Brain Barrier · 2021
  No notice
• The glycosylation in SARS-CoV-2 and its receptor ACE2 · 2021
  No notice
• COVID-19, immune system response, hyperinflammation and repurposing antirheumatic drugs · 2020
  No notice
• COVID-19: The biology behind the virion · 2020
  Not checked
• Probiotics in Medicine: A Long Debate · 2020
  No notice
• Is There a Link Between the Pathogenic Human Coronavirus Envelope Protein and Immunopathology? A Review of the Literature · 2020
  Not checked
• Overview of Immune Response During SARS-CoV-2 Infection: Lessons From the Past · 2020
  No notice

and 25 more

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.